DAVID POPLACK to Feasibility Studies
This is a "connection" page, showing publications DAVID POPLACK has written about Feasibility Studies.
Connection Strength
0.070
-
Intrathecal mafosfamide: a preclinical pharmacology and phase I trial. J Clin Oncol. 2005 Mar 01; 23(7):1555-63.
Score: 0.049
-
Methotrexate pharmacokinetics following administration of recombinant carboxypeptidase-G2 in rhesus monkeys. J Clin Oncol. 1992 Aug; 10(8):1359-64.
Score: 0.021